A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Juvenile Idiopathic Arthritis Who Completed WA19977 Core Study
Clinical trial NCT01667471 · COMPLETED
Trial details
- NCT number
- NCT01667471
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2013-08-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.